About Proteocyte
Proteocyte is a company based in Toronto (Canada) founded in 2011. Proteocyte has raised $1.97 million across 11 funding rounds from investors including Ontario Centre of Innovation, Golden Triangle Angel Network and Laurier Innovation. The company has 49 employees as of May 27, 2025. Proteocyte offers products and services including STRATICYTE and AI Diagnostic Services. Proteocyte operates in a competitive market with competitors including Viome Life Sciences, Vigilant Biosciences, Erly Sign, OralDNA and PeriRx, among others.
- Headquarter Toronto, Canada
- Employees 49 as on 27 May, 2025
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Proteocyte Diagnostics Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.97 M (USD)
in 11 rounds
-
Latest Funding Round
$21.7 K (USD), Series A
May 02, 2025
-
Investors
Ontario Centre of Innovation
& 3 more
-
Employee Count
49
as on May 27, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Proteocyte
Proteocyte offers a comprehensive portfolio of products and services, including STRATICYTE and AI Diagnostic Services.
Predicts oral cancer risk using biomarker analysis and AI.
Provides tools for early cancer detection and personalized treatment.
People of Proteocyte
Unlock access to complete
Unlock access to complete
Funding Insights of Proteocyte
Proteocyte has successfully raised a total of $1.97M across 11 strategic funding rounds. The most recent funding activity was a Series A round of $21.7 thousand completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Proteocyte
Proteocyte has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Ontario Centre of Innovation, Golden Triangle Angel Network and Laurier Innovation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech startups in Canada are supported through angel investments.
|
Locked | Locked | Locked | |
|
Freycinet Ventures is focused on supporting high-impact Canadian technology ventures.
|
Locked | Locked | Locked | |
|
Entrepreneurial talent is nurtured through programs at Laurier Innovation.
|
Locked | Locked | Locked |
Investor details for Proteocyte
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Proteocyte
Investment portfolio details for Proteocyte
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Proteocyte
Detailed financials for Proteocyte
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Proteocyte Comparisons
Peer comparison for Proteocyte
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Proteocyte
Proteocyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome Life Sciences, Vigilant Biosciences, Erly Sign, OralDNA and PeriRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
|
|
| Locked | Locked | Locked |
Solutions for early oral cancer detection are developed and provided.
|
|
| Locked | Locked | Locked |
A platform providing test kits for detecting oral cancer
|
|
| Locked | Locked | Locked |
Saliva-based tests for periodontal disease and infections are developed.
|
|
| Locked | Locked | Locked |
Saliva-based tests for oral cancer risk stratification are developed.
|
Detailed competitors of Proteocyte
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Proteocyte
Complete news archive for Proteocyte
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Proteocyte
Proteocyte was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Proteocyte is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Proteocyte is a funded company, having raised a total of $1.97M across 11 funding rounds to date.
As of May 27, 2025, the latest employee count at Proteocyte is 49.
Proteocyte was founded in 2011 in Toronto, Canada, within the medical diagnostics sector. Tests to assess cancer risk are developed and offered, focusing on oral cancers. The Straticyte product employs antibodies to identify biomarkers in lesion biopsies. Biomarker patterns are evaluated via a proprietary algorithm, enabling patient classification as high or low risk for oral cancer progression. Operations center on biopsy-based analysis for clinical decision support.
Proteocyte's top competitors include Viome Life Sciences, Erly Sign and Vigilant Biosciences.
Proteocyte offers STRATICYTE and AI Diagnostic Services.
Proteocyte has 4 investors. Key investors include Ontario Centre of Innovation, Golden Triangle Angel Network, Laurier Innovation, and Freycinet Ventures.